Integrated Palliative Care for Patients Referred for Chimeric Antigen Receptor (CAR) T-Cell Therapy: A Service Evaluation

J Pain Symptom Manage. 2024 Feb;67(2):e157-e159. doi: 10.1016/j.jpainsymman.2023.11.002. Epub 2023 Nov 8.

Authors

Rebekah Williams¹, Joanne Droney², Emma Nicholson², Carlos Gonzalez Arias², Rose Ellard², Nathalie Bradley², Celvin Maycock², Angela Halley²

Affiliations

¹ Symptom Control and Palliative Care Department, The Royal Marsden Hospital, London, United Kingdom; Haematology Department, The Royal Marsden Hospital, Sutton, United Kingdom. Electronic address: rwilliams@doctors.org.uk.
² Symptom Control and Palliative Care Department, The Royal Marsden Hospital, London, United Kingdom; Haematology Department, The Royal Marsden Hospital, Sutton, United Kingdom.

PMID: 37949255
DOI: 10.1016/j.jpainsymman.2023.11.002

No abstract available

Publication types

Letter

MeSH terms

Cell- and Tissue-Based Therapy
Hospice and Palliative Care Nursing*
Humans
Immunotherapy, Adoptive
Palliative Care
Receptors, Chimeric Antigen* / therapeutic use

Substances

Receptors, Chimeric Antigen